Nuveen’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Nuveen’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-414,106	Closed	-$1.05M	–	3338
2023 Q4	$1.05M	Buy	414,106 +3,919	+1%	+$9.13K	﹤0.01%	2712
2023 Q3	$980K	Sell	410,187 -4,446	-1%	-$9.84K	﹤0.01%	2582
2023 Q2	$958K	Hold	414,633	–	–	﹤0.01%	2682
2023 Q1	$1.06M	Sell	414,633 -39,234	-9%	-$112K	﹤0.01%	2588
2022 Q4	$1.14M	Sell	453,867 -108,644	-19%	-$303K	﹤0.01%	2634
2022 Q3	$1.63M	Buy	562,511 +39,193	+7%	+$165K	﹤0.01%	2505
2022 Q2	$2.37M	Buy	+523,318	New	+$3.11M	﹤0.01%	2346

Nuveen's SLGC Position: Q1 2024 in Review

Nuveen sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 414,106 shares — an estimated $1.05M sold.

Nuveen first reported a position in SLGC in Q2 2022 and held it in 7 quarters. The position peaked at $2.37M in Q2 2022. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

Nuveen reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
Nuveen sold 414,106 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $1.05M.
Nuveen first reported a position in SomaLogic, Inc. Class A Common Stock in Q2 2022 and held it in 7 quarters.
Nuveen's SomaLogic, Inc. Class A Common Stock position peaked at $2.37M in Q2 2022.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Nuveen's 13F filing for Q1 2024, filed 13 May 2024.